Algeta to Present at Upcoming Investor Conferences
Oslo, Norway, 3 December 2012 - Algeta ASA (OSE: ALGETA), a company focused on
the development of novel targeted cancer therapeutics, announces that members of
its senior management team will participate in the following investor
conferences:
DNB Nordic Healthcare Conference 2012
 Date: 6 December 2012
 Presenter: Andrew Kay (President & CEO)
Presentation time: 10:45am CET
 Venue: Oslo, Norway
J.P.Morgan Healthcare Conference 2013
 Date: 7-10 January 2013
 Presenter: Andrew Kay (President & CEO)
Presentation date/time: Tuesday 8 January, 2013, 4:00pm PT
 Venue: San Francisco, CA, USA
The presentations will be available to download at www.algeta.com following
these events.
###
For further information, please contact
Mike Booth +47 2202 4510
Communications & Corporate Affairs ir@algeta.com
Media enquiries:
Mark Swallow +44 207 638 9571
Citigate Dewe Rogerson mark.swallow@citigatedr.co.uk
Knut Ekern +47 22 04 82 00
Gambit Hill & Knowlton knut.ekern@hkstrategies.com
Kari Watson +1 781 235 3060
MacDougall Biomedical Communications kwatson@macbiocom.com
US investor enquiries:
Tricia Swanson +1 646 378 2953
The Trout Group tswanson@troutgroup.com
About Algeta
Algeta is a company focused on developing novel targeted therapies for patients
with cancer based on its alpha-pharmaceutical platform. The Company is
headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in
Cambridge, MA performing commercial marketing operations in the US. Algeta is
listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information please
visit www.algeta.com.
This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
Press release:
http://hugin.info/134655/R/1661790/538461.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Algeta ASA via Thomson Reuters ONE
[HUG#1661790]
